-
Je něco špatně v tomto záznamu ?
Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids
M. Rossmeisl, ZM. Jilkova, O. Kuda, T. Jelenik, D. Medrikova, B. Stankova, B. Kristinsson, GG. Haraldsson, H. Svensen, I. Stoknes, P. Sjövall, Y. Magnusson, MG. Balvers, KC. Verhoeckx, E. Tvrzicka, M. Bryhn, J. Kopecky,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
NS10528
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- analýza rozptylu MeSH
- bílá tuková tkáň metabolismus MeSH
- biologická dostupnost MeSH
- dieta s vysokým obsahem tuků MeSH
- endokanabinoidy MeSH
- fosfolipidy metabolismus MeSH
- imunohistochemie MeSH
- játra účinky léků metabolismus MeSH
- kosterní svaly metabolismus MeSH
- kvantitativní polymerázová řetězová reakce MeSH
- kyselina eikosapentaenová metabolismus MeSH
- kyseliny dokosahexaenové metabolismus MeSH
- metabolomika MeSH
- mikroskopie MeSH
- modulátory kanabinoidních receptorů metabolismus MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- obezita dietoterapie prevence a kontrola MeSH
- omega-3 mastné kyseliny aplikace a dávkování metabolismus farmakologie MeSH
- tělesná hmotnost MeSH
- triglyceridy metabolismus MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
BACKGROUND: n-3 polyunsaturated fatty acids, namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), reduce the risk of cardiovascular disease and can ameliorate many of obesity-associated disorders. We hypothesised that the latter effect will be more pronounced when DHA/EPA is supplemented as phospholipids rather than as triglycerides. METHODOLOGY/PRINCIPAL FINDINGS: In a 'prevention study', C57BL/6J mice were fed for 9 weeks on either a corn oil-based high-fat obesogenic diet (cHF; lipids ∼35% wt/wt), or cHF-based diets in which corn oil was partially replaced by DHA/EPA, admixed either as phospholipids or triglycerides from marine fish. The reversal of obesity was studied in mice subjected to the preceding cHF-feeding for 4 months. DHA/EPA administered as phospholipids prevented glucose intolerance and tended to reduce obesity better than triglycerides. Lipemia and hepatosteatosis were suppressed more in response to dietary phospholipids, in correlation with better bioavailability of DHA and EPA, and a higher DHA accumulation in the liver, white adipose tissue (WAT), and muscle phospholipids. In dietary obese mice, both DHA/EPA concentrates prevented a further weight gain, reduced plasma lipid levels to a similar extent, and tended to improve glucose tolerance. Importantly, only the phospholipid form reduced plasma insulin and adipocyte hypertrophy, while being more effective in reducing hepatic steatosis and low-grade inflammation of WAT. These beneficial effects were correlated with changes of endocannabinoid metabolome in WAT, where phospholipids reduced 2-arachidonoylglycerol, and were more effective in increasing anti-inflammatory lipids such as N-docosahexaenoylethanolamine. CONCLUSIONS/SIGNIFICANCE: Compared with triglycerides, dietary DHA/EPA administered as phospholipids are superior in preserving a healthy metabolic profile under obesogenic conditions, possibly reflecting better bioavalability and improved modulation of the endocannabinoid system activity in WAT.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000725
- 003
- CZ-PrNML
- 005
- 20141022100408.0
- 007
- ta
- 008
- 130108s2012 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0038834 $2 doi
- 035 __
- $a (PubMed)22701720
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Rossmeisl, Martin $u Department of Adipose Tissue Biology, Institute of Physiology Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic.
- 245 10
- $a Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids / $c M. Rossmeisl, ZM. Jilkova, O. Kuda, T. Jelenik, D. Medrikova, B. Stankova, B. Kristinsson, GG. Haraldsson, H. Svensen, I. Stoknes, P. Sjövall, Y. Magnusson, MG. Balvers, KC. Verhoeckx, E. Tvrzicka, M. Bryhn, J. Kopecky,
- 520 9_
- $a BACKGROUND: n-3 polyunsaturated fatty acids, namely docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), reduce the risk of cardiovascular disease and can ameliorate many of obesity-associated disorders. We hypothesised that the latter effect will be more pronounced when DHA/EPA is supplemented as phospholipids rather than as triglycerides. METHODOLOGY/PRINCIPAL FINDINGS: In a 'prevention study', C57BL/6J mice were fed for 9 weeks on either a corn oil-based high-fat obesogenic diet (cHF; lipids ∼35% wt/wt), or cHF-based diets in which corn oil was partially replaced by DHA/EPA, admixed either as phospholipids or triglycerides from marine fish. The reversal of obesity was studied in mice subjected to the preceding cHF-feeding for 4 months. DHA/EPA administered as phospholipids prevented glucose intolerance and tended to reduce obesity better than triglycerides. Lipemia and hepatosteatosis were suppressed more in response to dietary phospholipids, in correlation with better bioavailability of DHA and EPA, and a higher DHA accumulation in the liver, white adipose tissue (WAT), and muscle phospholipids. In dietary obese mice, both DHA/EPA concentrates prevented a further weight gain, reduced plasma lipid levels to a similar extent, and tended to improve glucose tolerance. Importantly, only the phospholipid form reduced plasma insulin and adipocyte hypertrophy, while being more effective in reducing hepatic steatosis and low-grade inflammation of WAT. These beneficial effects were correlated with changes of endocannabinoid metabolome in WAT, where phospholipids reduced 2-arachidonoylglycerol, and were more effective in increasing anti-inflammatory lipids such as N-docosahexaenoylethanolamine. CONCLUSIONS/SIGNIFICANCE: Compared with triglycerides, dietary DHA/EPA administered as phospholipids are superior in preserving a healthy metabolic profile under obesogenic conditions, possibly reflecting better bioavalability and improved modulation of the endocannabinoid system activity in WAT.
- 650 _2
- $a bílá tuková tkáň $x metabolismus $7 D052436
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a tělesná hmotnost $7 D001835
- 650 _2
- $a modulátory kanabinoidních receptorů $x metabolismus $7 D063385
- 650 _2
- $a dieta s vysokým obsahem tuků $7 D059305
- 650 _2
- $a kyseliny dokosahexaenové $x metabolismus $7 D004281
- 650 _2
- $a kyselina eikosapentaenová $x metabolismus $7 D015118
- 650 _2
- $a endokanabinoidy $7 D063388
- 650 _2
- $a omega-3 mastné kyseliny $x aplikace a dávkování $x metabolismus $x farmakologie $7 D015525
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolomika $7 D055432
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a mikroskopie $7 D008853
- 650 _2
- $a kosterní svaly $x metabolismus $7 D018482
- 650 _2
- $a obezita $x dietoterapie $x prevence a kontrola $7 D009765
- 650 _2
- $a fosfolipidy $x metabolismus $7 D010743
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a triglyceridy $x metabolismus $7 D014280
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jilkova, Zuzana Macek
- 700 1_
- $a Kuda, Ondrej
- 700 1_
- $a Jelenik, Tomas
- 700 1_
- $a Medrikova, Dasa
- 700 1_
- $a Stankova, Barbora
- 700 1_
- $a Kristinsson, Björn
- 700 1_
- $a Haraldsson, Gudmundur G
- 700 1_
- $a Svensen, Harald
- 700 1_
- $a Stoknes, Iren
- 700 1_
- $a Sjövall, Peter
- 700 1_
- $a Magnusson, Ylva
- 700 1_
- $a Balvers, Michiel G J
- 700 1_
- $a Verhoeckx, Kitty C M
- 700 1_
- $a Tvrzicka, Eva
- 700 1_
- $a Bryhn, Morten
- 700 1_
- $a Kopecky, Jan
- 773 0_
- $w MED00180950 $t PLoS ONE $x 1932-6203 $g Roč. 7, č. 6 (2012), s. e38834
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22701720 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20141022100406 $b ABA008
- 999 __
- $a ok $b bmc $g 963507 $s 798889
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 7 $c 6 $d e38834 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- GRA __
- $a NS10528 $p MZ0
- LZP __
- $a Pubmed-20130108